Indicator summary: Leaning bearish (1 bullish, 3 bearish, 1 neutral). As of 2026-11-05, the close was $12.01: 11.1% below the 50-day average and 5.6% below the 200-day average, which is rising. RSI (14) is 41, in its neutral range. MACD is bearish. The stock sits 44% of the way up its 52-week range of $9.80 to $14.86, on 1.7x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $13.51 | Price 11.1% below |
| 200-day average | $12.73 | Price 5.6% below, average rising |
| 50 vs 200-day | 50 above 200 | Golden-cross alignment |
| RSI (14) | 41 | Neutral range |
| MACD (12, 26, 9) | -0.55 vs -0.52 | Line below signal |
| 52-week range | $9.80 to $14.86 | 44% of the way up the range |
| Volume vs 20-day average | 1.7x | Heavy |
Base rates use SAN's own daily history since 1999; they describe the past, not a forecast.
As of 2026-11-05, SAN's 14-day RSI is 41, which is in the neutral range between 30 and 70.
No. SAN closed at $12.01 on 2026-11-05, 5.6% below its 200-day average of $12.73, which is rising. When it closed below its 200-day average (2,768 days), it was higher 63 trading days later 48% of the time, median -1.0%.
No. SAN closed at $12.01 on 2026-11-05, 11.1% below its 50-day average of $13.51. When it closed below its 50-day average (3,018 days), it was higher 63 trading days later 55% of the time, median +2.6%.
No cross in the last 10 trading days. As of 2026-11-05 the MACD line is -0.55 against a signal line of -0.52, so MACD is bearish.
No. At $12.01 it sits 44% of the way up its 52-week range of $9.80 to $14.86, 19.2% below the high.
Leaning bearish: 1 of 5 indicators are bullish and 3 bearish as of 2026-11-05 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Bullish, from the chart signal model.
SAN analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.